You are here

Home

Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald
Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft
Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

U.S. could have 300 million extra vaccine doses by end of July; more calls to provide to other nations

Thu, 2021-04-15 12:25 — mike kraft
U.S. could have 300 million extra vaccine doses by end of July, raising concerns about hoarding The Biden administration is facing renewed pressure to facilitate equitable vaccine distribution around the world. Adam Taylor, Emily Rauhala Washington Post
 
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Vaccinations
Cooperation
Government
Health
Pandemics
Problem, Solution, SitRep, or ?: 
Situation Report

Higher risk of brain clots from COVID-19 than from vaccines--UK study

Thu, 2021-04-15 12:08 — mike kraft
UK scientists find higher risk of brain clots from COVID-19 compared with vaccines There is a much higher risk of brain blood clots from COVID-19 infection than there is from vaccines against the disease, British researchers said on Thursday, after the rollout of inoculations was disrupted by reports of rare clots. Alistair Smout Reuters
Country / Region Tags: 
Europe
Global
UK - London
United Kingdom
United States
General Topic Tags: 
COVID-19
Data
Vaccinations
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

How New Mexico Became the State With the Highest Rate of Full Vaccinations

Thu, 2021-04-15 11:11 — mike kraft

ALBUQUERQUE — Despite having one of the highest poverty rates in the country, New Mexico is surging past states with far more resources in the race to achieve herd immunity against the coronavirus.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Public Attitudes
Public Health
Vaccinations
Contagion
Disease
Government
Pandemics
Policy
Problem, Solution, SitRep, or ?: 
Situation Report

CDC study supports leaving airplane middle seats open to reduce COVID-19 exposure

Wed, 2021-04-14 18:38 — mike kraft
CDC study: Leaving middle seat open on planes could reduce COVID-19 A Centers for Disease Control and Prevention (CDC) study found leaving the middle seat vacant on planes could reduce COVID-19 exposure for passengers, supporting a practice that has now been Justine Coleman TheHill
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Disease Prevention
Social distancing
Contagion
Disease
Government
Health
Pandemics
Research
Transportation
Problem, Solution, SitRep, or ?: 
Analysis

UPDATE: Johnson & Johnson vaccine pause to continue as CDC committee postpones decision

Wed, 2021-04-14 18:04 — mike kraft
J&J vaccine to remain in limbo while officials seek evidence Johnson & Johnson's COVID-19 vaccine will remain in limbo a while longer after U.S. health advisers told the government Wednesday that they need more evidence to decide if a handful of unusual... AP NEWS

Johnson & Johnson’s COVID-19 vaccine will remain in limbo a while longer after U.S. health advisers told the government Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the potential risk really is.

Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Vaccinations
Government
Health
Policy
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Headache appears to be initial symptom of vaccine blood clotting events --CDC official

Wed, 2021-04-14 17:42 — mike kraft
Headache appears to be initial symptom of blood clotting events, CDC's vaccine safety lead says Headache appears to be the main symptom among the six women who developed blood clots after receiving a Johnson & Johnson coronavirus vaccine, Dr. Tom Shimabukuro, vaccine safety lead with the US Centers for Disease Control and Prevention's Covid-19 Response Team, said during a meeting of the CDC's Advisory Committee on Immunization Practices on Wednesday. By Jessie Yeung and Kara Fox, CNN CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Vaccinations
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Report from federal advisory board discussions of J&J vaccine

Wed, 2021-04-14 17:33 — mike kraft
CDC vaccine advisers review Johnson & Johnson shot after reports of rare blood clots Federal health officials had recommended Tuesday that states pause use of the vaccine while agencies review six U.S. cases of a rare and severe type of brain blood clot among the more than 7 million people who received the shot. Lena H. Sun, Carolyn Y. Johnson Washington Post
Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Vaccinations
Contagion
Disease
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

OPINION: The new vaccine threat is fear itself

Wed, 2021-04-14 11:42 — mike kraft
The new vaccine threat is fear itself The Johnson & Johnson pause is the latest example of how we've struggled to keep COVID risks in perspective. Sam Baker Axios

The FDA’s decision to pause the use of Johnson & Johnson's coronavirus vaccine has set off a chain reaction of fear — about the safety of the vaccine, and about whether the FDA is overreacting — that's causing unnecessary drama just as the vaccine effort is finally picking up speed.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Public Attitudes
Vaccinations
Government
Health
Pandemics
Policy
Problem, Solution, SitRep, or ?: 
Analysis

Overview: Europeans assessing J&J vaccines, plus international briefs ,

Wed, 2021-04-14 11:25 — mike kraft
The Latest: European agency expects J&J recommendation soon LONDON -- The European Medicines Agency is assessing the rare blood clots reported in the U.S. after receiving the Johnson & Johnson COVID-19 vaccine, and a recommendation for European countries... AP NEWS
Country / Region Tags: 
Europe
Global
India
United Nations
United States
General Topic Tags: 
COVID-19
Data
Vaccinations
Contagion
Disease
Government
Health
Pandemics
Problem, Solution, SitRep, or ?: 
Situation Report

Colleges that planned to vaccinate students have to deal with temporary J&J pause

Wed, 2021-04-14 10:59 — mike kraft
Colleges that intended to vaccinate students with J&J navigate the temporary pause For colleges and universities, the one-shot Johnson & Johnson COVID-19 shot has been the simplest solution for quickly and fully vaccinating students who will soon disperse around the country in early May, otherwise risking both infection and transmission as they go. Schools that had other vaccine options on hand said they would reschedule students to get Pfizer or Moderna shots -- but students would then have to figure out how to get their second shot in three to four weeks if they planned to be home for the summer by then.
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Vaccinations
Contagion
Disease
Education
Health
Pandemics
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

howdy folks
Page loaded in 0.683 seconds.